Diabetes treatment depends on the type you have, but the core options fall into a few major categories: lifestyle changes, oral medications, injectable therapies, glucose monitoring, and in some cases, surgery. Most people with type 2 diabetes start with diet and exercise changes alongside medication, while type 1 diabetes always requires insulin. The good news is that treatment options have expanded significantly in recent years, giving people more ways to manage blood sugar effectively and, for some with type 2, even achieve remission.
Lifestyle Changes: Diet and Exercise
For type 2 diabetes, lifestyle changes are the foundation of every treatment plan. They work alongside medications, not as a replacement, though in early-stage type 2 diabetes they can sometimes be enough on their own. The two biggest levers are what you eat and how much you move.
On the food side, the simplest approach is the plate method: start with a 9-inch dinner plate and fill half with non-starchy vegetables like broccoli, salad greens, or green beans. Fill one quarter with lean protein (chicken, beans, tofu, eggs) and the remaining quarter with carbohydrate foods like rice, bread, or fruit. This naturally controls portion size and limits the carbs that spike your blood sugar the most. Some people take it further with carb counting, tracking the grams of carbohydrates at each meal and keeping them within a target range set with their care team.
Weight loss makes a meaningful difference for people with type 2 diabetes who carry extra weight. Even a modest reduction, around 5 to 7 percent of body weight, improves how your body responds to insulin and can lower blood sugar enough to reduce medication needs. Regular physical activity helps independently of weight loss too. It makes your muscles better at pulling sugar from the blood, an effect that lasts for hours after you stop moving. A mix of aerobic exercise (walking, cycling, swimming) and resistance training tends to produce the best results.
Metformin and Other Oral Medications
Metformin is typically the first medication prescribed for type 2 diabetes. It works by reducing the amount of sugar your liver releases into the bloodstream and by helping your cells respond better to insulin. It’s inexpensive, well-studied over decades, and doesn’t cause weight gain. The most common side effects are digestive: nausea, bloating, and diarrhea, which usually improve after a few weeks as your body adjusts.
If metformin alone isn’t enough, your doctor may add a second oral medication from a different class. Sulfonylureas stimulate your pancreas to produce more insulin. They’re effective and affordable, but they can cause low blood sugar episodes and some weight gain. DPP-4 inhibitors take a different approach: they block an enzyme that normally breaks down hormones called incretins, which help your body use insulin more efficiently after meals. Side effects are generally mild (headache, stuffy nose, joint pain), though there’s a small increased risk of pancreatitis. SGLT2 inhibitors are another option. They work in the kidneys, causing excess sugar to leave your body through urine. Beyond blood sugar control, this class has shown benefits for heart and kidney health.
Injectable Therapies: GLP-1 and Dual Agonists
Injectable medications that mimic gut hormones have become some of the most effective treatments for type 2 diabetes. GLP-1 receptor agonists (like semaglutide) and newer dual-action drugs (like tirzepatide, which targets two gut hormones simultaneously) lower blood sugar while also promoting significant weight loss.
In real-world data comparing the two, patients starting tirzepatide saw an average blood sugar reduction of 1.3 percentage points on their HbA1c (a three-month blood sugar average) and lost about 10.2 kilograms (roughly 22 pounds). Those on semaglutide had a 0.9 percentage point HbA1c drop and lost about 6.1 kilograms (13 pounds). Both are meaningful improvements. These medications are given as weekly injections using a small pen device, which most people find far less daunting than they expected.
Nausea is the most common side effect, especially in the first few weeks as the dose gradually increases. Starting low and stepping up slowly helps most people tolerate it. These drugs are prescribed for type 2 diabetes but are not used for type 1.
Insulin Therapy
Everyone with type 1 diabetes needs insulin because their body produces none. Many people with type 2 diabetes eventually need it too, particularly if the pancreas produces less insulin over time. Insulin isn’t a failure of treatment. It’s simply the next step when other options can’t keep blood sugar in a safe range.
Insulin comes in several forms designed for different jobs:
- Rapid-acting insulin starts working in about 15 minutes, peaks at 1 hour, and lasts 2 to 4 hours. You take it right before or with meals to handle the blood sugar spike from food.
- Short-acting (regular) insulin kicks in within 30 minutes, peaks at 2 to 3 hours, and lasts 3 to 6 hours. It covers meals but with a slightly longer lead time.
- Intermediate-acting insulin takes 2 to 4 hours to start, peaks between 4 and 12 hours, and covers 12 to 18 hours. It provides background coverage for part of the day.
- Long-acting insulin begins working in about 2 hours, doesn’t have a pronounced peak, and lasts up to 24 hours. It provides a steady baseline of insulin throughout the day.
Many people use a combination: a long-acting insulin once or twice daily for background control, plus a rapid-acting insulin at meals. Insulin pumps, which deliver a continuous small dose through a tiny tube under the skin, are another option, especially popular for type 1 diabetes. Modern pumps can pair with continuous glucose monitors to adjust delivery automatically.
Continuous Glucose Monitoring
Continuous glucose monitors (CGMs) use a tiny sensor inserted just under the skin to measure blood sugar every few minutes, giving you a real-time number on your phone or a receiver. This is a significant upgrade from traditional finger-stick testing, which only captures a single moment. With a CGM, you can see how food, exercise, stress, and sleep affect your blood sugar throughout the day.
The key metric from a CGM is “time in range,” meaning the percentage of the day your blood sugar stays between 70 and 180 mg/dL. The general target for most adults with type 1 or type 2 diabetes is at least 70% of the day in range, which works out to roughly 17 hours out of 24. Higher time in range correlates with lower risk of long-term complications like nerve damage, kidney disease, and eye problems. For many people, seeing the real-time data changes behavior in ways that abstract lab numbers don’t. You quickly learn which meals spike you and which don’t.
Bariatric Surgery
For people with type 2 diabetes and a BMI of 35 or higher (and sometimes lower), weight-loss surgery can produce dramatic improvements in blood sugar. Two common procedures are gastric bypass, which reroutes part of the digestive tract, and sleeve gastrectomy, which removes a large portion of the stomach.
At one year after surgery, about 57% of gastric bypass patients and 47% of sleeve gastrectomy patients achieved diabetes remission in a pooled analysis of clinical trials. By the two-to-five-year mark, remission rates between the two procedures were similar. Surgery works partly through weight loss and partly through hormonal changes in the gut that improve insulin sensitivity almost immediately, sometimes before significant weight is lost. It’s not a casual decision. It requires lifelong dietary changes, vitamin supplementation, and follow-up care. But for people who qualify, it’s one of the most effective interventions available.
What Diabetes Remission Looks Like
Remission is possible for some people with type 2 diabetes, though it’s not guaranteed. An international expert consensus defines remission as maintaining an HbA1c below 6.5% for at least three months without taking any diabetes medication. This can happen through substantial weight loss, whether achieved through lifestyle changes, medication, or surgery.
Remission doesn’t mean cure. The underlying tendency toward insulin resistance remains, and blood sugar can climb again over time, especially if weight is regained. People in remission still need regular monitoring. But reaching that threshold is a realistic goal for some, particularly those diagnosed recently who haven’t yet lost significant insulin-producing capacity in the pancreas.